Darolutamide plus ADT and radiotherapy improves metastasis free survival in very high risk prostate cancer
Darolutamide plus ADT and radiotherapy improves metastasis free survival in very high risk prostate cancer
Divarasib improves survival in previously treated KRAS G12C mutated advanced NSCLC
Dostarlimab achieves durable complete clinical responses in dMMR/MSI-H locally advanced rectal cancer
ESMO 2026: Advances in NMIBC and MIBC
Safeguarding the right to work for people with advanced breast cancer (ABC) and their caregivers: A global snapshot of legislati
Equitable precision oncology in Africa
Sequencing breast cancer scale-up in LMICs: Using service assessment to shape national priorities in Ethiopia
Cost of standard-of-care cancer treatment and financing gaps under AB PM-JAY in India
Choice of wording may influence global acceptance of adapted childhood cancer treatment guidelines
Multilevel factors shaping blinatumomab delivery across diverse LMICs
Building the cancer system of the future in UAE
Designing around lives: A decentralised, people-centred oncology care architecture from India